Tak Paul Peter — SEC insider filings

SEC reporting owner CIK 1873905. 18 insider filings on record with FilingPulse; latest filed 2026-09-11.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-08-02 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Candel Therapeutics, Inc. (CADL)Chief Executive Officer, Director183 legs · 40,985 sh · $230,0209 legs · 440,961 sh · $4,210,77512

Insider filings — Tak Paul Peter

FiledFormIssuerReported transactionsSource
2026-09-114Candel Therapeutics, Inc. (CADL)Option exercise (M): 125,000 @ $1.55 · Sale (S): 220,866 @ $11.50 · Sale (S): 59,379 @ $10.46 · Option exercise (M): 125,000 (derivative) @ $0EDGAR
2026-01-284Candel Therapeutics, Inc. (CADL)Grant/award (A): 629,000 (derivative) @ $0EDGAR
2025-06-264Candel Therapeutics, Inc. (CADL)Grant/award (A): 42,826 @ $4.67EDGAR
2025-03-204Candel Therapeutics, Inc. (CADL)Sale (S): 25,772 @ $8.77 · Sale (S): 400 @ $9.00EDGAR
2025-02-144Candel Therapeutics, Inc. (CADL)Grant/award (A): 525,000 (derivative) @ $0EDGAR
2025-01-174Candel Therapeutics, Inc. (CADL)Sale (S): 21,704 @ $7.22EDGAR
2025-01-104Candel Therapeutics, Inc. (CADL)Sale (S): 21,172 @ $8.22EDGAR
2024-12-034Candel Therapeutics, Inc. (CADL)Sale (S): 48,847 @ $4.56EDGAR
2024-11-214Candel Therapeutics, Inc. (CADL)Option exercise (M): 12,900 @ $1.55 · Option exercise (M): 12,900 (derivative) @ $0EDGAR
2024-07-194Candel Therapeutics, Inc. (CADL)Sale (S): 22,528 @ $6.47EDGAR
2024-07-154Candel Therapeutics, Inc. (CADL)Sale (S): 20,293 @ $5.97EDGAR
2023-11-304Candel Therapeutics, Inc. (CADL)Tax withholding (F): 43,443 @ $0.90EDGAR
2023-11-284Candel Therapeutics, Inc. (CADL)Grant/award (A): 180,108 @ $0EDGAR
2023-05-024Candel Therapeutics, Inc. (CADL)Grant/award (A): 180,000 (derivative) @ $0EDGAR
2022-12-124Candel Therapeutics, Inc. (CADL)Purchase (P): 3,050 @ $1.70 · Purchase (P): 12,935 @ $1.92EDGAR
2022-11-304Candel Therapeutics, Inc. (CADL)Grant/award (A): 195,906 @ $0EDGAR
2022-03-014Candel Therapeutics, Inc. (CADL)Grant/award (A): 330,000 (derivative) @ $0EDGAR
2021-08-024Candel Therapeutics, Inc. (CADL)Purchase (P): 25,000 @ $8EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-07-30 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1873905 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs